SSR3
Basic information
Region (hg38): 3:156539553-156555149
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SSR3 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 8 | |||||
missense | 12 | 12 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | 2 | |||
non coding | 6 | |||||
Total | 0 | 0 | 13 | 9 | 4 |
Variants in SSR3
This is a list of pathogenic ClinVar variants found in the SSR3 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
3-156543230-G-A | Likely benign (Jun 14, 2024) | |||
3-156543249-C-T | Uncertain significance (Dec 07, 2024) | |||
3-156543253-T-C | not specified | Uncertain significance (Oct 03, 2023) | ||
3-156543286-G-A | Likely benign (Jul 19, 2023) | |||
3-156544317-T-C | Uncertain significance (Mar 25, 2024) | |||
3-156544339-A-G | not specified | Uncertain significance (Nov 30, 2021) | ||
3-156544357-C-T | Uncertain significance (Jun 24, 2024) | |||
3-156544358-G-A | Likely benign (Jan 15, 2023) | |||
3-156544390-A-C | not specified | Uncertain significance (Dec 06, 2022) | ||
3-156544396-T-C | Uncertain significance (Oct 19, 2024) | |||
3-156544412-A-T | Likely benign (Mar 01, 2023) | |||
3-156544421-A-G | Benign (Dec 16, 2024) | |||
3-156544443-C-G | Benign (Feb 03, 2025) | |||
3-156544453-A-G | Likely benign (Nov 22, 2022) | |||
3-156548853-C-T | Benign (Feb 03, 2025) | |||
3-156548896-G-A | Uncertain significance (Oct 13, 2023) | |||
3-156548916-C-G | Uncertain significance (Sep 12, 2023) | |||
3-156548935-C-T | Uncertain significance (Dec 07, 2023) | |||
3-156548976-A-G | Benign (Jan 23, 2025) | |||
3-156548982-ATCCT-A | Congenital disorder of glycosylation | Likely pathogenic (-) | ||
3-156548985-C-T | Benign (Feb 02, 2025) | |||
3-156553646-C-T | Likely benign (Nov 02, 2023) | |||
3-156553647-ATACT-A | Uncertain significance (Nov 29, 2023) | |||
3-156553675-C-T | Likely benign (Mar 12, 2022) | |||
3-156553699-C-T | Likely benign (Sep 07, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
SSR3 | protein_coding | protein_coding | ENST00000265044 | 5 | 15045 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.747 | 0.251 | 125117 | 0 | 1 | 125118 | 0.00000400 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.770 | 75 | 96.3 | 0.779 | 0.00000448 | 1208 |
Missense in Polyphen | 10 | 27.418 | 0.36473 | 420 | ||
Synonymous | -1.01 | 45 | 37.2 | 1.21 | 0.00000178 | 353 |
Loss of Function | 2.45 | 1 | 8.88 | 0.113 | 4.40e-7 | 111 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.00000882 | 0.00000882 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: TRAP proteins are part of a complex whose function is to bind calcium to the ER membrane and thereby regulate the retention of ER resident proteins.;
- Pathway
- Protein processing in endoplasmic reticulum - Homo sapiens (human);SRP-dependent cotranslational protein targeting to membrane;Translation;Metabolism of proteins
(Consensus)
Recessive Scores
- pRec
- 0.130
Intolerance Scores
- loftool
- 0.307
- rvis_EVS
- -0.23
- rvis_percentile_EVS
- 36.86
Haploinsufficiency Scores
- pHI
- 0.170
- hipred
- Y
- hipred_score
- 0.754
- ghis
- 0.628
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.934
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Ssr3
- Phenotype
- mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); embryo phenotype; respiratory system phenotype; cellular phenotype; growth/size/body region phenotype;
Gene ontology
- Biological process
- SRP-dependent cotranslational protein targeting to membrane
- Cellular component
- endoplasmic reticulum membrane;integral component of membrane
- Molecular function